Effectiveness of needle and syringe programmes for preventing HIV transmission

International Journal of Drug Policy

Volumn 14, Issue 5-6, 2003, Pages 353-357

  MacDonald, Margaret ^a   Law, Matthew ^a   Kaldor, John ^a   Hales, Jim ^b   Dore, Gregory J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Hlth Outcomes Intl Pty Ltd   (Australia)

Author keywords

Australia; HIV prevention; Syringe exchange programmes

Indexed keywords

ARTICLE; CITY; COMPUTER PROGRAM; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DRUG USE; ELECTRONICS; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INJECTION; MEDICAL LITERATURE; NEEDLE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEROPREVALENCE; SYRINGE; VIRUS TRANSMISSION;

EID: 0242491033     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(03)00133-6     Document Type: Article

References (11)

1. Bruneau J., Lamothe F., Franco E. High rates of HIV infection among injecting drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology. 145:1997;994-1002.
2. Des Jarlais D.C., Hagan H.R., Friedman S.R.et al. Maintaining low HIV seroprevalences in populations of injecting drug users. The Journal of the American Medical Association. 274:1995;1226-1231.
3. Des Jarlais D.C., Marmor M., Paone D.et al. HIV incidence among injecting drug users in New York City syringe-exchange programs. Lancet. 348:1996;987-991.
4. Drucker E., Lurie P., Wodak A., Alcabes P. Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS. 12(Suppl. A):1998;S217-S230.
5. Fischer B., Rehm J., Blitz-Miller T. Injection drug use and preventative measures: A comparison of Canadian and Western European jurisdictions over time. Canadian Medical Association Journal. 162:2000;1709-1713.
6. Hagen H., McGough J.P., Thiede H.et al. Syringe exchange and risk of infection with hepatitis B and C viruses. American Journal of Epidemiology. 149:1999;203-213.
7. Hahn J.A., Vranizan K.M., Moss A.R. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 15(2):1997;157-164.
8. Hurley S.F., Jolley D.J., Kaldor J.M. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 349:1997;1797-1800.
9. Miller C.L., Tyndall M., Spittal P., Li K., Palepu A.et al. Risk-taking behaviours among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. Journal of Urban Health. 79(2):2002;257-265.
10. US Census Bureau UNAIDS Collaborating Centre. (2000). HIV/AIDS Surveillance Data Base. Health Studies Branch, International Programs Center, Population Division, U.S. Census Bureau, Washington.
11. Van Ameijden E.J.C., Van den Hoek J.A.R., Mientjes G.H.C., Coutinho R.A. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. European Journal of Epidemiology. 9:1993;225-262.